Shingles, commonly known as herpes zoster, is a virus that attacks the brain's cranial nerves. It's caused by the varicella zoster virus, which is also responsible for chicken pox. Because the virus can remain dormant in the human body for several years, everyone who has had chicken pox before is at risk of acquiring shingles. According to the Centers for Disease Control and Prevention (CDC), one million cases of shingles were reported in the United States in 2018. Furthermore, the Centers for Disease Control and Prevention (CDC) estimates that one out of every three people in the United States will develop shingles at some point in their lives.
The Shingles Vaccine Market has extended across the globe, with Europe, North America, the Middle East and Africa, Asia Pacific, and Latin America all having a share. In the next years, the North American region is expected to occupy a prominent position in the market. The presence of important competitors in the region has contributed to the market's growth. Between 2016 and 2024, North America and Europe are estimated to account for the majority of the market. The market in North America is likely to rise because to rising demand in the United States, while the market in Europe is expected to grow due to increased therapeutic demand from the European Union.
The risk of shingles increases with age, with the majority of occurrences occurring in adults over the age of 40.This is primarily due to a weakened immune system as a result of increased stress and insufficient consumption of vital nutrients to maintain immunity. Skin rashes, nerve discomfort, eyesight loss, cold, upset stomach, muscle weakness, skin infection, and scarring are some of the symptoms. Antiviral medications such as acyclovir, valacyclovir, and famciclovir are used to treat shingles. These medications aid in reducing the length and intensity of the sickness. Furthermore, analgesics may aid in pain relief.
Over the projected period, the Asia Pacific shingles vaccine market is expected to develop at the fastest rate. In the region, particularly in China and India, there is a large potential market that has to be exploited. Companies would benefit from active marketing and differential pricing to strengthen their market position in Asia Pacific.
